Late July is peak US cherry season, and the annual wave of tart cherry juice marketing has arrived with it — this year alongside a broader wellness push toward high-dose vitamin C for “inflammation support” during a summer of record heat and heavy outdoor training. Both claims share a common ancestor: a small set of real, published studies that found something genuine, then got compressed into headlines that promise far more than the data support. This article does the unglamorous thing and reads the studies. Cherries and vitamin C are not useless for gout, but what they can plausibly do is narrower and smaller than the label copy suggests.
What the Zhang 2012 cherry study actually showed
This is the study behind nearly every cherry-and-gout claim you will encounter, and it is worth being precise about it. Zhang and colleagues recruited 633 individuals with physician-diagnosed gout and followed them online for one year, collecting information about each flare and about exposures in the two days preceding it. Using a case-crossover design, each participant served as their own control — their exposure before a flare was compared with their exposure during a flare-free control period.
The finding was consistent: cherry intake in the prior two days was associated with a 35% lower odds of an attack. Cherry extract showed a similar association. The effect appeared to strengthen with dose up to about three servings over two days, and plateaued after that. Participants taking allopurinol alongside cherry intake had a 75% lower odds of attack than those with neither.
Now the limits, which the authors themselves stated plainly. This was observational, not a randomised trial — it can identify an association, not establish that cherries caused the reduction. Intake was self-reported, with all the recall error that implies. Participants knew they were in a gout study, and people who eat cherries specifically because they believe it helps may differ systematically from those who do not. There was no placebo arm. And the outcome was self-reported flares rather than clinician-confirmed events. The authors concluded that findings “need to be confirmed in a randomised trial” — and fourteen years later, an adequately powered trial of that kind still has not been published.
Subsequent work has been mixed and small. Some short trials of tart cherry juice concentrate have reported modest reductions in serum urate and in inflammatory markers such as CRP; others found no significant urate change. Sample sizes are typically under 50, durations are measured in days to weeks, and formulations differ enormously between studies. A 2019 systematic review of cherry supplementation for gout concluded that the evidence base was too heterogeneous and low-quality to support firm recommendations. That is not a refutation — it is a statement that the question remains open.
Why cherries might do something
The proposed mechanism is plausible, which is part of why the idea persists. Cherries — particularly tart Montmorency varieties — are dense in anthocyanins, the pigments responsible for their colour. Anthocyanins have demonstrated anti-inflammatory activity in laboratory models, including inhibition of cyclooxygenase enzymes. There is also in vitro evidence that some cherry compounds may inhibit xanthine oxidase, the enzyme that produces uric acid, and that anthocyanins may influence renal urate transporters.
Plausible mechanism and clinical effect are different things, though. The concentrations achieved in cell culture generally far exceed what you reach in plasma after eating a bowl of cherries, and the observed urate reductions in human studies, where present, are small — on the order of 5–15 µmol/L. For context, urate-lowering therapy aims to bring serum urate below 360 µmol/L (6 mg/dL), which often requires reductions several times larger than anything diet alone has been shown to deliver. Our pages on fresh dark sweet cherries and tart cherry juice list the purine and sugar figures for each format.
One practical caveat about juice: concentrating cherries into a drinkable form concentrates their sugar too. A typical 8-ounce serving of tart cherry juice carries a meaningful fructose load, and fructose has its own documented relationship with urate production. If you are drinking cherry juice daily on the theory that it lowers uric acid, you may be partially offsetting the benefit you are chasing. Whole fruit avoids that trade-off.
Vitamin C: a real signal that failed the clinical test
The vitamin C story follows a similar shape but ends in a more informative place, because here the randomised trials were actually done.
The observational groundwork was strong. Choi and colleagues, analysing 46,994 men over 20 years in the Health Professionals Follow-up Study, reported that higher vitamin C intake was associated with lower gout risk, with men consuming 1,500 mg or more per day showing a 45% lower risk than those consuming under 250 mg (Arch Intern Med, 2009). Mechanistically this made sense — vitamin C appears to be uricosuric, increasing renal excretion of urate, possibly through competition at the URAT1 transporter.
A 2011 meta-analysis by Juraschek and colleagues pooled 13 randomised controlled trials and found that vitamin C supplementation, median 500 mg/day for a median of 30 days, reduced serum uric acid by an average of 0.35 mg/dL (about 20 µmol/L). Statistically significant, but clinically modest.
Then came the test that mattered. Stamp and colleagues randomised patients with established gout to vitamin C 500 mg daily, allopurinol, or both. Vitamin C alone produced no clinically significant reduction in serum urate in people with gout, and adding it to allopurinol provided no additional benefit over increasing the allopurinol dose (Arthritis Rheum, 2013). The distinction is critical: a supplement that nudges urate slightly downward in healthy volunteers is not the same as a treatment that works in people who already have the disease.
This is why the 2020 American College of Rheumatology guideline issued a conditional recommendation against vitamin C supplementation specifically for the purpose of managing gout. It is not a safety warning — vitamin C from food is unambiguously good for you, and citrus fruits, peppers, and berries are worth eating for many reasons. It is a statement that supplementation should not be relied on as urate-lowering therapy. You can compare vitamin C-dense options on our citrus fruits page.
How to fit both into a real diet
Neither cherries nor vitamin C is a treatment. Both can reasonably be part of an eating pattern.
- Eat cherries in season because they are a good food. Low in purines, rich in polyphenols, high in water content. If you find they coincide with fewer flares, that is worth noting in a food diary — but keep taking prescribed medication.
- Prefer whole cherries to juice or concentrate when practical, to avoid the added sugar load.
- Get vitamin C from food. A cup of strawberries, half a bell pepper, or an orange each supply substantial amounts without the megadose question.
- Do not substitute either for urate-lowering therapy. The 2020 ACR guideline is explicit that dietary change produces only modest urate reductions relative to pharmacological treatment.
- Watch the interactions that matter more. Alcohol, sugar-sweetened drinks, and high-purine meats have larger and better-documented effects. See our flare triggers guide.
If you want the purine numbers for a particular cherry product, you can search “cherry” in the FoodCanEat database to compare fresh, canned, and juice formats.
Frequently Asked Questions
How many cherries would I need to eat for the effect seen in the study?
In the Zhang 2012 analysis, one serving was defined as roughly half a cup, or approximately 10 to 12 cherries, and the association appeared to strengthen up to about three servings consumed over a two-day period before plateauing. Higher intake did not show additional benefit in that dataset. It is important to keep the study design in mind: this was an observational case-crossover analysis based on self-reported intake, so the figures describe a pattern that was associated with fewer reported flares, not a validated dose. There is no established therapeutic dose of cherries for gout, and no randomised trial has confirmed the finding. Treat half a cup to a cup daily in season as a reasonable food choice rather than a prescription.
Is tart cherry juice better than fresh cherries?
There is no good evidence that it is. Tart Montmorency varieties do contain higher anthocyanin concentrations than sweet dark cherries, which is the usual argument for concentrate products, and some small trials have used juice specifically. However, concentrating cherries into juice also concentrates their fructose, and fructose has a documented association with increased urate production through hepatic ATP depletion. Juice also removes fibre and is consumed faster than whole fruit. Given that the underlying evidence for either format is limited and observational, the more conservative choice is whole fresh or frozen cherries, with juice as an occasional option rather than a daily supplement.
Should I take a vitamin C supplement for gout?
Current guidance does not support it for that purpose. Observational data suggested a benefit, and a 2011 meta-analysis of randomised trials found a small average reduction in serum urate of about 0.35 mg/dL, but a randomised trial in people with established gout found that 500 mg daily produced no clinically significant urate reduction and added nothing to allopurinol therapy. On that basis the 2020 American College of Rheumatology guideline conditionally recommends against vitamin C supplementation for gout management. Vitamin C from food remains valuable for general health, and there is no reason to reduce your intake of citrus, berries, or peppers. Discuss any supplement plans with your clinician, particularly if you take other medications.
References: Zhang Y, Neogi T, Chen C, Chaisson C, Hunter DJ, Choi HK. Cherry consumption and decreased risk of recurrent gout attacks. Arthritis Rheum. 2012;64(12):4004–4011. • Juraschek SP, Miller ER 3rd, Gelber AC. Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials. Arthritis Care Res. 2011;63(9):1295–1306. • Stamp LK, O'Donnell JL, Frampton C, Drake JM, Zhang M, Chapman PT. Clinically insignificant effect of supplemental vitamin C on serum urate in patients with gout: a pilot randomized controlled trial. Arthritis Rheum. 2013;65(6):1636–1642. • Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med. 2009;169(5):502–507. • FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020;72(6):744–760.